Higashi H - Search Results

1

Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators.

Suzuki-Takahashi I, Higashi H, Yoshida E, Nishimura S, Kitagawa M. Suzuki-Takahashi I, et al. Among authors: higashi h. Biochem Biophys Res Commun. 1997 May 19;234(2):386-92. doi: 10.1006/bbrc.1997.6654. Biochem Biophys Res Commun. 1997. PMID: 9177281

2

Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.

Higashi H, Suzuki-Takahashi I, Taya Y, Segawa K, Nishimura S, Kitagawa M. Higashi H, et al. Biochem Biophys Res Commun. 1995 Nov 13;216(2):520-5. doi: 10.1006/bbrc.1995.2653. Biochem Biophys Res Commun. 1995. PMID: 7488142

3

The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.

Suzuki-Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S, Okuyama A. Suzuki-Takahashi I, et al. Among authors: higashi h. Oncogene. 1995 May 4;10(9):1691-8. Oncogene. 1995. PMID: 7753545

4

Phosphorylation of E2F-1 by cyclin A-cdk2.

Kitagawa M, Higashi H, Suzuki-Takahashi I, Segawa K, Hanks SK, Taya Y, Nishimura S, Okuyama A. Kitagawa M, et al. Among authors: higashi h. Oncogene. 1995 Jan 19;10(2):229-36. Oncogene. 1995. PMID: 7838523

5

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y. Kitagawa M, et al. Among authors: higashi h. EMBO J. 1996 Dec 16;15(24):7060-9. EMBO J. 1996. PMID: 9003781 Free PMC article.

6

Expression of p16INK4a suppresses the unbounded and anchorage-independent growth of a glioblastoma cell line that lacks p16INK4a.

Higashi H, Suzuki-Takahashi I, Yoshida E, Nishimura S, Kitagawa M. Higashi H, et al. Biochem Biophys Res Commun. 1997 Feb 24;231(3):743-50. doi: 10.1006/bbrc.1997.6181. Biochem Biophys Res Commun. 1997. PMID: 9070885

7

A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.

Kitagawa M, Higashi H, Takahashi IS, Okabe T, Ogino H, Taya Y, Hishimura S, Okuyama A. Kitagawa M, et al. Among authors: higashi h. Oncogene. 1994 Sep;9(9):2549-57. Oncogene. 1994. PMID: 8058318

8

Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H, et al. Kitagawa M, et al. Among authors: higashi h. Oncogene. 1993 Sep;8(9):2425-32. Oncogene. 1993. PMID: 8395680

9

Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.

Higashi H, Suzuki-Takahashi I, Saitoh S, Segawa K, Taya Y, Okuyama A, Nishimura S, Kitagawa M. Higashi H, et al. Eur J Biochem. 1996 Apr 15;237(2):460-7. doi: 10.1111/j.1432-1033.1996.0460k.x. Eur J Biochem. 1996. PMID: 8647086 Free article.

10

Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex.

Terano T, Tanaka T, Tamura Y, Kitagawa M, Higashi H, Saito Y, Hirai A. Terano T, et al. Among authors: higashi h. Biochem Biophys Res Commun. 1999 Jan 19;254(2):502-6. doi: 10.1006/bbrc.1998.9976. Biochem Biophys Res Commun. 1999. PMID: 9918868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

818 results

Search Page

Filters